18F-COX-2 inhibitor (Helmholtz-Zentrum Dresden-Rossendorf/Technische Universität Dresden)

N/A

Report date: 2025/01/26 18:11:50

Base Information

Drug Name18F-COX-2 inhibitor (Helmholtz-Zentrum Dresden-Rossendorf/Technische Universität Dresden)
Drug Alias NameN/A
ClassificationRadiation-emitting products
Mechanisms of ActionCyclooxygenase-2 modulators
TargetsCyclooxygenase-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHelmholtz-Zentrum Dresden-Rossendorf
China Registration ClassN/A

Develop Information

Active CompaniesTechnische Universitat DresdenHelmholtz-Zentrum Dresden-Rossendorf
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A